Investigational Drug Information for Sym004
✉ Email this page to a colleague
What is the drug development status for Sym004?
Sym004 is an investigational drug.
There have been 11 clinical trials for Sym004.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2019.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Carcinoma, and Colonic Neoplasms. The leading clinical trial sponsors are Symphogen A/S, Merck KGaA, Darmstadt, Germany, and EMD Serono.
There are two US patents protecting this investigational drug and thirty-eight international patents.
Summary for Sym004
| US Patents | 2 |
| International Patents | 38 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2019-02-01) |
| Vendors | 0 |
Recent Clinical Trials for Sym004
| Title | Sponsor | Phase |
|---|---|---|
| Sym004 Versus TAS-102 in Patients With mCRC | Symphogen A/S | Phase 3 |
| Sym004 Versus Futuximab or Modotuximab in Patients With mCRC | Symphogen A/S | Phase 2 |
| Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients | Symphogen A/S | Phase 2 |
Clinical Trial Summary for Sym004
Top disease conditions for Sym004
Top clinical trial sponsors for Sym004
US Patents for Sym004
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sym004 | ⤷ Try a Trial | Binding molecules specific for HER3 and uses thereof | MEDIMMUNE, LLC (Gaithersburg, MD) | ⤷ Try a Trial |
| Sym004 | ⤷ Try a Trial | Methods for assessing and identifying or evolving conditionally active therapeutic proteins | Halozyme, Inc. (San Diego, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sym004
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sym004 | Australia | AU2012340766 | 2031-11-23 | ⤷ Try a Trial |
| Sym004 | Brazil | BR112014012539 | 2031-11-23 | ⤷ Try a Trial |
| Sym004 | Canada | CA2856297 | 2031-11-23 | ⤷ Try a Trial |
| Sym004 | China | CN104093743 | 2031-11-23 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
